TRANS-6A-ALPHA-12-ALPHA-PHENYL-1,2,3,4,5,6A,7,8,9,10,10A,12-DODECAHYDROBENZIMIDAZO-[2,1-B]-QUINAZOLINE
Compound with spectra: 1 NMR
![TRANS-6A-ALPHA-12-ALPHA-PHENYL-1,2,3,4,5,6A,7,8,9,10,10A,12-DODECAHYDROBENZIMIDAZO-[2,1-B]-QUINAZOLINE](/api/compound/DRdu16ttzTM.png?ph=true&h=300&w=458 "TRANS-6A-ALPHA-12-ALPHA-PHENYL-1,2,3,4,5,6A,7,8,9,10,10A,12-DODECAHYDROBENZIMIDAZO-[2,1-B]-QUINAZOLINE")
| SpectraBase Compound ID | DRdu16ttzTM |
|---|---|
| InChI | InChI=1S/C20H25N3/c1-2-8-14(9-3-1)19-15-10-4-5-11-16(15)21-20-22-17-12-6-7-13-18(17)23(19)20/h1-3,8-9,17-19H,4-7,10-13H2,(H,21,22)/t17-,18-,19+/m0/s1 |
| InChIKey | GWFZISOGXQHLBD-GBESFXJTSA-N |
| Mol Weight | 307.44 g/mol |
| Molecular Formula | C20H25N3 |
| Exact Mass | 307.204848 g/mol |
| Enantiomer InChIKey | GWFZISOGXQHLBD-QRVBRYPASA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6:CDCl3 |
TRANS-6A-ALPHA-12-BETA-(PARA-TOLYL)-1,2,3,4,5,6A,7,8,9,10,10A,12-DODECAHYDROBENZIMIDAZO-[2,1-B]-QUINAZOLINE
TRANS-6A-ALPHA-12-BETA-(PARA-TOLYL)-1,2,3,4,5,6A,7,8,9,10,10A,12-DODECAHYDROBENZIMIDAZO-[2,1-B]-QUINAZOLINE-HYDROCHLORIDE
(2S,2' S)-{N-[2'-(Ethylamino)-3'-phenylpropionyl}bornane-10,12-sultam
(9a' R)-7'-[Indol-3"-yl)methyl]octahydro-2'-(2-phenylethyl)-spiro(cyclopropane-1,1'-[2H]-pyrazino[1,2-a]pyrazine-3',6',9'-trione
(9a' S)-7'-[Indol-3"-yl)methyl]octahydro-2'-(2-phenylethyl)-spiro(cyclopropane-1,1'-[2H]-pyrazino[1,2-a]pyrazine-3',6',9'-trione
2-Methyl-4-(4-acetylphenyl)-3-(2-furylethenyl)isoxazolino[4,5-c]quinolines
2-Methyl-4-[4-cyanophenyl]-3-(4-methylphenyl)-isoxazolino[4,5-c]quinoline
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and Structure Elucidation of Pyrimidobenzimidazoles and Fused Derivatives II [1]. Dodecahydrobenzimidazo-[2,1-b]quinazolines and Decahydrobenzimidazo-[2,1-b]benzo[h]quinazolines [2] | Monatshefte für Chemie/Chemical Monthly | 2000 |